Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             127 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: Implications for therapy of cognitive dysfunction in schizophrenia McLean, Samantha L.
2011
21 Supplement 1 p. 333-343
11 p.
artikel
2 A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial Mathew, Sanjay J.
2011
21 Supplement 1 p. 221-229
9 p.
artikel
3 Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex Tordera, R.M.
2011
21 Supplement 1 p. 23-32
10 p.
artikel
4 C.12.01 The keys to improving depression outcomes Kennedy, S.
2011
21 Supplement 1 p. S635-
1 p.
artikel
5 C.11.02 Therapeutic strategies Swartz, H.
2011
21 Supplement 1 p. S634-S635
2 p.
artikel
6 C.07.01 The vagaries of diagnosis in the mood and psychotic disorders: clinical implications Castle, D.J.
2011
21 Supplement 1 p. S629-
1 p.
artikel
7 Differential gene expression in mutant mice overexpressing or deficient in the serotonin transporter: A focus on urocortin 1 Fabre, Véronique
2011
21 Supplement 1 p. 33-44
12 p.
artikel
8 Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats Crunelle, Cleo L.
2011
21 Supplement 1 p. 205-210
6 p.
artikel
9 Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers Andreou, Dimitrios
2011
21 Supplement 1 p. 700-704
5 p.
artikel
10 E.03.02 Current and future treatment options Eckert, A.
2011
21 Supplement 1 p. S234-
1 p.
artikel
11 Editorial Board 2011
21 Supplement 1 p. IFC-
1 p.
artikel
12 Editorial Board 2011
21 Supplement 1 p. IFC-
1 p.
artikel
13 Effects of olanzapine on extracellular concentrations and tissue content of neurotensin in rat brain regions Gruber, Susanne H.M.
2011
21 Supplement 1 p. 918-927
10 p.
artikel
14 Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons Fraguas, David
2011
21 Supplement 1 p. 621-645
25 p.
artikel
15 E.01.01 Overview Bradford, J.
2011
21 Supplement 1 p. S233-
1 p.
artikel
16 Erk activation in the amygdala and hippocampus induced by fear conditioning in ethanol withdrawn rats: Modulation by mk-801 Bertotto, María Eugenia
2011
21 Supplement 1 p. 892-904
13 p.
artikel
17 Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice Dhir, Ashish
2011
21 Supplement 1 p. 705-714
10 p.
artikel
18 Insulin receptor signaling in rat hippocampus: A study in STZ (ICV) induced memory deficit model Agrawal, Rahul
2011
21 Supplement 1 p. 261-273
13 p.
artikel
19 In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: Involvement of dopamine D1 and alpha 2 adrenergic receptors Gronier, Benjamin
2011
21 Supplement 1 p. 192-204
13 p.
artikel
20 Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors Pobbe, Roger L.H.
2011
21 Supplement 1 p. 306-315
10 p.
artikel
21 Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice Singer, Philipp
2011
21 Supplement 1 p. 401-413
13 p.
artikel
22 P.7.a.004 Assessment of sleep characteristics of patients with attention deficit hyperactivity disorder by actigraphy Jeong, J.H.
2011
21 Supplement 1 p. S601-S602
2 p.
artikel
23 P.1.a.022 Association analysis of polymorphisms on neuregulin 1 (nrg1) gene with schizophrenia in the Korean population Woo, S.
2011
21 Supplement 1 p. S249-
1 p.
artikel
24 P.1.a.011 Association between BDNF gene and psychosis in a Spanish population Varela, N.
2011
21 Supplement 1 p. S243-
1 p.
artikel
25 P.6.a.011 Chronic cocaine use increases alcohol-cue appetitiveness in subjects with and without alcohol dependence Rubio, G.
2011
21 Supplement 1 p. S565-
1 p.
artikel
26 P.2.a.002 Cognitive functions among women and men suffering from depressive disorders Talarowska, M.
2011
21 Supplement 1 p. S354-S355
2 p.
artikel
27 P.8.a.004 Correlation between anxiety symptom and suicidal ideation Kim, S.I.
2011
21 Supplement 1 p. S612-S613
2 p.
artikel
28 P.4.009 Afobazol as inhibitor of NRH: quinone reductase 2 enzyme Kadnikov, I.
2011
21 Supplement 1 p. S149-S150
2 p.
artikel
29 P.3.a.011 Frequency of substance use disorders in patients with schizophrenia in Morocco El Omari, F.
2011
21 Supplement 1 p. S459-
1 p.
artikel
30 P.4.a.010 Full and partial PTSD among 475 young adult survivors 20 months after the L'Aquila 2009 earthquake: impact of loss events Dell'Osso, L.
2011
21 Supplement 1 p. S531-
1 p.
artikel
31 P.2.a.019 Impact of insomnia on treatment of depression in adolescents Emslie, G.
2011
21 Supplement 1 p. S364-S365
2 p.
artikel
32 P.8.a.018 Impact of methylphenidate treatment on the rate of accidents in adults with Attention Deficit Hyperactivity Disorder (ADHD) Marin, M.
2011
21 Supplement 1 p. S620-S621
2 p.
artikel
33 P.6.a.008 Piracetam in the treatment of sleep disorders and exacerbations of craving in alcoholic and heroin addicted patients Altshuler, V.B.
2011
21 Supplement 1 p. S563-S564
2 p.
artikel
34 P.2.020 AS101 antidepressant-like effects in rat models for depression Saida, H.
2011
21 Supplement 1 p. S50-
1 p.
artikel
35 P.5.b.003 ABCG 2 gene polymorphism in Alzheimer's disease Feher, A.
2011
21 Supplement 1 p. S549-S550
2 p.
artikel
36 P.2.b.019 Ablated neurogenic response to fluoxetine in female p11 knockout mice Egeland, M.
2011
21 Supplement 1 p. S378-
1 p.
artikel
37 P.4.b.013 A functional NPSR gene polymorphism influences personality and impulsivity in a longitudinal study Laas, K.
2011
21 Supplement 1 p. S540-
1 p.
artikel
38 P.6.b.010 Aminophylline as antioxidant agent associated to ethanol (subchronic) effects in the central nervous system of mice Cordeiro, R.C.
2011
21 Supplement 1 p. S573-
1 p.
artikel
39 P.1.025 BDNF gene and personality traits in anorexia nervosa patients and healthy subjects Dmitrzak-Weglarz, M.
2011
21 Supplement 1 p. S129-S130
2 p.
artikel
40 P.1.011 Behavioural characterisation of magnesium effects in rats Samardzic, J.
2011
21 Supplement 1 p. S122-
1 p.
artikel
41 P.2.b.003 Expression of the insulin-like growth factor-1 receptor in the rat hippocampus following prenatal stress Szczesny, E.
2011
21 Supplement 1 p. S369-
1 p.
artikel
42 P.6.b.014 NOS 1 gene Ex1f-VNTR polymorphism influences alcohol consumption in humans Laas, K.
2011
21 Supplement 1 p. S575-
1 p.
artikel
43 P.2.b.022 Psychosocial stress in tree shrews induces hormonal alterations accompanied by lateralised cytoskeletal changes in the hippocampus Parésys, L.
2011
21 Supplement 1 p. S380-
1 p.
artikel
44 P.1.b.003 Stereological estimation of the substantia nigra neurons in 6-ODHA-lesioned rats receiving L-DOPA and the nitric oxide donor molsidomine Czarnecka, A.
2011
21 Supplement 1 p. S251-
1 p.
artikel
45 P.2.b.009 The melanin-concentrating hormone system and emotional-like behaviour García-Fuster, M.J.
2011
21 Supplement 1 p. S372-S373
2 p.
artikel
46 P.1.b.006 Time course of histological changes following the 4-vessel occlusion/internal carotid arteries model of chronic cerebral hypoperfusion Valério, C. Romanini
2011
21 Supplement 1 p. S253-
1 p.
artikel
47 P.2.c.024 A double-blind, randomised, placebocontrolled, relapse-prevention study with Lu AA21004 in patients with major depressive disorder Dragheim, M.
2011
21 Supplement 1 p. S396-S397
2 p.
artikel
48 P.1.c.048 Alpha 1 antagonist in dorsal raphe mediates analgesia induced by defence behaviour evoked by stimulation of the dorsomedial hypothalamus Salgado, C.J.
2011
21 Supplement 1 p. S280-S281
2 p.
artikel
49 P.1.c.038 Anticonvulsant effect of hydroalcoholic extract of Zizyphus jujuba: pharmacodynamic and pharmacokinetic interaction with phenytoin Reeta, K.H.
2011
21 Supplement 1 p. S274-S275
2 p.
artikel
50 P.3.c.018 Assessing the reliability of Tanner Staging in CNS trials: A cross-cultural comparison of European, US, and Indian raters Rothman, B.
2011
21 Supplement 1 p. S478-
1 p.
artikel
51 P.1.c.010 Cytochrome P450 mediates the synthesis of monoaminergic neurotransmitters in the brain Daniel, W.A.
2011
21 Supplement 1 p. S258-S259
2 p.
artikel
52 P.3.c.035 Differential effects of aripiprazole versus risperidone on sexual performance, negative symptoms or emotional flatness (anhedonia) de Boer, M.K.
2011
21 Supplement 1 p. S488-S489
2 p.
artikel
53 P.3.c.004 Impact of addiction on cognitive and social functioning in one of twin brothers suffering from schizophrenia Krysta, K.
2011
21 Supplement 1 p. S469-S470
2 p.
artikel
54 P.3.c.059 Incidence, onset, and duration of treatment-emergent somnolence with asenapine in adult patients with schizophrenia or bipolar disorder Szegedi, A.
2011
21 Supplement 1 p. S502-S503
2 p.
artikel
55 P.2.c.027 Inverse correlation between plasma levels of the endocannabinoid, 2-arachidonylglycerol, and severity of symptoms in patients with major depression Xenos, D.
2011
21 Supplement 1 p. S398-
1 p.
artikel
56 P.1.c.055 Metadoxine:a novel 5HT-2B receptor antagonist with a possible therapeutic role in treating ADHD Daniely, Y.
2011
21 Supplement 1 p. S284-S285
2 p.
artikel
57 P.6.005 Comparative study of the abuse potential of the kappa-opoioid agonist RU-1203 Grechko, O.
2011
21 Supplement 1 p. S162-S163
2 p.
artikel
58 P.1.c.040 Partial occupancy of the glycine transporter type 1 by RG1678 leads to efficacy in animal models relevant to schizophrenia Alberati, D.
2011
21 Supplement 1 p. S275-S276
2 p.
artikel
59 P.3.c.001 Quetiapine as a monotherapy for bipolar disorder Istikoglou, C.
2011
21 Supplement 1 p. S468-
1 p.
artikel
60 P.3.c.045 Schizophrenia with obsessive-compulsive symptoms Alfonso, A. Pampin
2011
21 Supplement 1 p. S494-
1 p.
artikel
61 P.3.c.032 Spectrum of middle-mass endotoxic molecules and antibodies to DNA in schizophrenia patients with tardive dyskinesia Ivanova, A.S.
2011
21 Supplement 1 p. S486-S487
2 p.
artikel
62 P.2.c.010 The change of platelet counts after administrations of escitalopram, venlafaxine, bupropion in depressive patients Bahk, W.
2011
21 Supplement 1 p. S388-S389
2 p.
artikel
63 P.1.c.024 The effect of the brain noradrenergic system on liver cytochrome P450: the role of neuroendocrine regulation Haduch, A.
2011
21 Supplement 1 p. S266-S267
2 p.
artikel
64 P.1.c.041 The effects of 5-HT1B receptor modulation on glutamatergic neurotransmission in vivo Alvarsson, A.
2011
21 Supplement 1 p. S276-S277
2 p.
artikel
65 P.6.d.002 Activation of 5-HT1B receptors enhances the reinforcing activity of amphetamine in a self-administration model in rats Miszkiel, J.
2011
21 Supplement 1 p. S583-
1 p.
artikel
66 P.2.d.023 Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress Mocaër, E.
2011
21 Supplement 1 p. S414-S415
2 p.
artikel
67 P.5.d.001 1-Benzyl-1,2,3,4-tetrahydroisoquinoline triggered an increase of caspase-3 activity and prevented L-DOPA-induced effects in rat brain Antkiewicz-Michaluk, L.
2011
21 Supplement 1 p. S555-
1 p.
artikel
68 P.1.d.008 Blockade of D2 receptor with low dose of 17b-estradiol corrects depression-like behaviour in female rats Fedotova, J.
2011
21 Supplement 1 p. S294-S295
2 p.
artikel
69 P.5.d.002 Cholinergic neurons containing Rac1b in basal ganglia during neurofibrillary tangle formation in Alzheimer's disease Getova, D.
2011
21 Supplement 1 p. S555-S556
2 p.
artikel
70 P.2.d.026 Chronic administration of quetiapine increases norepinephrine and serotonin neurotransmission in the rat brain Chernoloz, O.
2011
21 Supplement 1 p. S416-S417
2 p.
artikel
71 P.4.d.002 Chronic CB2r blockade resulted in anxiolytic action and increased cannabinoid-2 receptor (CB2r), GABAaAlpha2, GABAaGamma2 mRNA levels in cortex and amygdala of mice García-Gutiérrez, M.S.
2011
21 Supplement 1 p. S541-S542
2 p.
artikel
72 P.1.d.022 Novel synthetic inhibitor of dipeptidyl peptidase IV, methionyl-2(S)-cyanopyrrolidine, induces latent aggression in rats Khlebnikova, N.
2011
21 Supplement 1 p. S302-
1 p.
artikel
73 P.6.d.006 Reduced immunoreactive cannabinoid-1 receptor (CB1) protein in brains of human cocaine addicts and cocaine-treated rats: role of endocannabinoids Bartolomé, M. Álvaro
2011
21 Supplement 1 p. S585-S586
2 p.
artikel
74 P.2.d.009 Repeated treatment with antidepressants and risperidone changed the reactivity of the central serotonin system in mice Rogóz, Z.
2011
21 Supplement 1 p. S406-S407
2 p.
artikel
75 P.6.d.016 Striatum, addiction and cognition Jansma, J.M.
2011
21 Supplement 1 p. S591-S592
2 p.
artikel
76 P.6.d.019 Zinc modulates morphine-induced behavioural sensitisation Chelarescu, D.
2011
21 Supplement 1 p. S593-
1 p.
artikel
77 P.1.e.002 Aging effects on the changes of regional cerebral blood flow in schizophrenia Wake, R.
2011
21 Supplement 1 p. S304-
1 p.
artikel
78 P.3.e.015 Charles Bonnet syndrome: successful treatment of visual hallucinations due to vision loss with trazodone in three cases Hsu, H.
2011
21 Supplement 1 p. S520-S521
2 p.
artikel
79 P.3.e.001 Efficacy and tolerability of sodium valproate versus lithium carbonate in schizoaffective disorder Sulejmanpasic, G.A.
2011
21 Supplement 1 p. S512-S513
2 p.
artikel
80 P.6.014 Effect of mitochondrial antioxidant SKQ-1 on the behaviour of albino rats after acute ethanol intoxication Efimova, E.V.
2011
21 Supplement 1 p. S167-S168
2 p.
artikel
81 P.1.e.026 Influence of catecholamine depletion on the striatal activation associated with appetitive conditioning Soelch, C. Martin
2011
21 Supplement 1 p. S318-
1 p.
artikel
82 P.2.e.009 Morning serum cortisol during euthymia in bipolar 1 and 2 disorder compared with healthy controls Johansson, A.G.M.
2011
21 Supplement 1 p. S422-S423
2 p.
artikel
83 P.3.e.018 Needs and quality of life in schizophrenic outpatients treated with risperidone or haloperidol Vukic, D.
2011
21 Supplement 1 p. S522-S523
2 p.
artikel
84 P.2.e.013 Olanzapine induced tardive dyskinesia in an adolescent with bipolar disorder treated succesfully with vitamin E: a case report Tufan, A.
2011
21 Supplement 1 p. S425-
1 p.
artikel
85 P.7.e.005 Pharmacological mechanisms involved in the electrophysiological effects of methylphenidate on prefrontal cortex neurons Gronier, B.
2011
21 Supplement 1 p. S610-S611
2 p.
artikel
86 P.1.e.016 Rapid gray matter density changes after selective-serotonin-reuptake-inhibitor administration revealed by voxel-basedmorphometry Savli, M.
2011
21 Supplement 1 p. S312-
1 p.
artikel
87 P.2.e.008 The impact of brief depressive episodes on the outcome of bipolar and major depressive disorder: a 1-year prospective study Serati, M.
2011
21 Supplement 1 p. S422-
1 p.
artikel
88 P.1.f.005 The cortisol awakening response during adolescence Platje, E.
2011
21 Supplement 1 p. S328-S329
2 p.
artikel
89 P.1.f.002 The effects of early post-natal treatment with ketamine on learning, memory and nociception in rats Doncheva, N.
2011
21 Supplement 1 p. S326-S327
2 p.
artikel
90 P.2.g.019 Aripiprazole treatment in children and adolescents with severe mood and behavioural dysregulation: a case series Inal-Emiroglu, F.
2011
21 Supplement 1 p. S451-
1 p.
artikel
91 P.2.g.002 Characteristics of hospitalised patients with depression and painful physical symptoms Rijavec, N.
2011
21 Supplement 1 p. S441-
1 p.
artikel
92 P.1.g.014 Cognition and functioning of patients with first psychotic episode and relation with BDNF García-Lecumberri, B.
2011
21 Supplement 1 p. S336-S337
2 p.
artikel
93 P.1.g.028 Cognitive effects and Fluoro Jade-C staining in the assessment of 2-vessel occlusion model of brain ischemia in mice Schiavon, A.P.
2011
21 Supplement 1 p. S344-S345
2 p.
artikel
94 P.2.g.016 Depressive symptoms in coronary artery disease patients: association with neuro-endocrine factors Bunevicius, A.
2011
21 Supplement 1 p. S449-
1 p.
artikel
95 P.1.g.031 Protective effect of L-valine derivative on declined cognitive function in isolated rats with early maternal deprivation Encheva, E.
2011
21 Supplement 1 p. S346-
1 p.
artikel
96 P.2.h.002 Some regional changes of alpha-1-adrenergic receptor density in rat brain depend on duration of chronic mild stress Bielawski, A.
2011
21 Supplement 1 p. S452-
1 p.
artikel
97 P.8.002 Hydrolysis of 1-methyl-5-phenyl-3-acetoxy-7-bromo-1,2-dihydro-3H-1,4-benzodiazepine-2-one with the help of pig liver microsomes Shesterenko, E.A.
2011
21 Supplement 1 p. S172-S173
2 p.
artikel
98 P.8.001 Investigation of patients' satisfaction with treatment in a mental hospital Semenova, N.V.
2011
21 Supplement 1 p. S172-
1 p.
artikel
99 P.2.023 In vivo microdialysis studies of brain dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction Wydra, K.
2011
21 Supplement 1 p. S52-S53
2 p.
artikel
100 P.2.006 Lesions of the ventral medial prefrontal cortex enhance contextual fear generalisation in C57BL6/J mice Courtin, J.
2011
21 Supplement 1 p. S38-S39
2 p.
artikel
101 P.1.027 Modulation of the neurotrophin brain-derived neurotrophic factor in serotonin transporter mutant rats Macchi, F.
2011
21 Supplement 1 p. S23-S24
2 p.
artikel
102 P.5.006 Piracetam treatment and cognitive performance of patients with mild cognitive impairment Borkowska, A.
2011
21 Supplement 1 p. S157-
1 p.
artikel
103 P.3.008 Predictors of response to antidepressant treatment in bipolar depression Murru, A.
2011
21 Supplement 1 p. S65-
1 p.
artikel
104 P.4.004 Schizophrenia-like phenotypes induced by genetic over-expression of brain andenosine kinase - a potential novel antipsychotic target Singer, P.
2011
21 Supplement 1 p. S81-
1 p.
artikel
105 P.1.028 Serum levels of somatostatin-28 and its binding sites in medial habenular nucleus differentiate rats responding and non responding to chronic mild stress Faron-Górecka, A.
2011
21 Supplement 1 p. S131-S132
2 p.
artikel
106 P.4.014 Targeting the alpha7 nicotinic receptor subtype to restore working memory deficits in rats following sub-chronic ketamine exposure Rushforth, S.
2011
21 Supplement 1 p. S89-S90
2 p.
artikel
107 P.4.006 The bioavailability of afobazol and compound M-11 in rats Bastrygin, D.V.
2011
21 Supplement 1 p. S147-S148
2 p.
artikel
108 P.1.013 The cannabinoid-1 receptor antagonist rimonabant increases striatal dopamine D2/3 receptor availability in rats van de Giessen, E.
2011
21 Supplement 1 p. S12-S13
2 p.
artikel
109 P.2.006 The effects of ZP-122 on prolyl endopeptidase activity in the brain structures of C57BL/6 and Balb/C mice after Porsolt test Shipilov, I.A.
2011
21 Supplement 1 p. S139-S140
2 p.
artikel
110 P.1.032 Where and when ketamine alters the dopamine system: translational implications for drug addiction and psychoses Calandro, S.
2011
21 Supplement 1 p. S26-S27
2 p.
artikel
111 S.07.08 A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy Koychev, I.
2011
21 Supplement 1 p. S197-S198
2 p.
artikel
112 S.05.02 Cognitive and information processing approaches Frangou, S.
2011
21 Supplement 1 p. S192-
1 p.
artikel
113 S.25.05 Early intervention in bipolar disorders: opportunities and pitfalls Berk, M.
2011
21 Supplement 1 p. S226-
1 p.
artikel
114 S.15.03 From the gene to behaviour to more genes: the mu-opioid receptor as an example in addiction research Kieffer, B.
2011
21 Supplement 1 p. S210-
1 p.
artikel
115 S.18.02 Functional polymorphisms in oxidative and nitrosative stress genes Galecki, P.
2011
21 Supplement 1 p. S214-S215
2 p.
artikel
116 S.12.03 Gender-dependent sensory gating in antipsychotic naive first-episode schizophrenia patients Oranje, B.
2011
21 Supplement 1 p. S204-
1 p.
artikel
117 S.08.03 Ghrelin and drug reward Engel, J.A.
2011
21 Supplement 1 p. S198-S199
2 p.
artikel
118 S.28.02 Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats Vengeliene, V.
2011
21 Supplement 1 p. S230-
1 p.
artikel
119 Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression Hoyle, D.
2011
21 Supplement 1 p. 3-10
8 p.
artikel
120 S.02.04 Innovative psychosocial interventions for bipolar disorder Vieta, E.
2011
21 Supplement 1 p. S186-
1 p.
artikel
121 S.21.04 Intensive intervention in first episode of psychosis – does it make a difference in the long term and for whom? Nordentoft, M.
2011
21 Supplement 1 p. S220-
1 p.
artikel
122 S.3.03 Inter-individual differences in impulsivity and underlying neurobiology Dalley, J.W.
2011
21 Supplement 1 p. S112-S113
2 p.
artikel
123 S.17.04 Magnetic resonance imaging correlates of cognitive and neuropsychiatric disturbances in multiple sclerosis Filippi, M.
2011
21 Supplement 1 p. S213-
1 p.
artikel
124 S.2.05 Psychoeducation and shared decision making as a way to reduce non-compliance in mental disorders Leucht, S.
2011
21 Supplement 1 p. S109-S110
2 p.
artikel
125 S.01.04 The HERV family of new biological entities and their neuroinflammatory properties Perron, H.
2011
21 Supplement 1 p. S185-
1 p.
artikel
126 The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats Holly, Elizabeth N.
2011
21 Supplement 1 p. 526-531
6 p.
artikel
127 The size and burden of mental disorders and other disorders of the brain in Europe 2010 Wittchen, H.U.
2011
21 Supplement 1 p. 655-679
25 p.
artikel
                             127 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland